Advocacy Archives – Page 3 of 8 – Treatment Action Group

Lessons Learned from HBCU Responses to the COVID-19 Pandemic

June 9, 2022
Dorrit Walsh

Please join us on June 30 for this free webinar where we discuss the lessons learned from COVID-19 protocols and policies implemented by HBCUs, along with student perspectives that will help inform responses to future pandemics or other public health emergencies.

cover of publication: An Advocate's Introduction to SARS-CoV-2 Rapid Diagnostic Testing, there's a drawing on the cover of a hand holding up two types of COVID rapid tests

Test and Treat COVID-19: An Advocate’s Introduction to SARS-CoV-2 Rapid Diagnostic Testing

June 7, 2022
Dorrit Walsh

All people have the right to know their COVID-19 status and to be able to use that information to protect themselves, their families, and their communities. Rapid antigen tests can be used at home or in informal settings to reliably and quickly detect cases of COVID-19, to guide decisions on interventions such as self-isolation, contact tracing, and antiviral treatment.

World Malaria Day 2022 Long-Acting Technologies Community Advisory Board (LAT-CAB) Statement

May 16, 2022
Dorrit Walsh

As the global Long-Acting Technologies Community Advisory Board (LAT CAB) representing 12 countries, vast civil society networks, and people living with and affected by malaira, HIV, tuberculosis, and hepatitis C across the world – in reflection of World Malaria Day on April 25, 2022 – we are shocked and united in anger at the health disparities and slow progress in meeting malaria eradication goals set out in the WHO Global Technical Strategy for Malaria 2016-2030.

U.S. Government Funded Research Brings Shorter Tuberculosis Treatment Regimens to New York City

May 16, 2022
Dorrit Walsh

We applaud the New York City Department of Health and Mental Hygiene (DoHMH) for its leadership as one of the first TB programs in the U.S. and globally to introduce a new four-month regimen for the treatment of drug-susceptible tuberculosis (TB).

Joint Statement from Leading HIV/AIDS and Viral Hepatitis Advocates regarding Manufacturer Action on the 340B Drug Pricing Program

April 20, 2022
Dorrit Walsh

A group of six leading HIV/AIDS and viral hepatitis advocates today released the following joint statement regarding recent manufacturer action against the 340B Drug Pricing Program:

TAG Submission to WHO Public Hearing Regarding a New International Instrument on Pandemic Preparedness and Response

April 13, 2022
Dorrit Walsh

At the first of these two public hearings TAG submitted the following statement with six reasons why the new international instrument must explicitly acknowledge the right to science as a central guiding framework.

The Right to Prevent TB

March 17, 2022
Dorrit Walsh

It’s now easier than ever to prevent TB before it develops into active disease or spreads within communities.

Mourning Paul Farmer, Honoring His Legacy

February 23, 2022
Dorrit Walsh

TAG’s staff and board of directors are filled with grief at the premature death of Dr. Paul Farmer, who illuminated and changed our world with his combination of passion, intelligence, solidarity with the poor, and determined will for social justice.

HIV Research Advocacy Fact Sheet

October 26, 2021
Dorrit Walsh

HIV advocacy laid the foundation for much of the work we do today. This handout was developed in collaboration with the Black AIDS Institute, HIV Vaccine Trials Network, and Southern AIDS Coalition. The handout provides a summary of the history…

graphic from Breaking Barriers summary that shows why covid-19 and HIV remain prevalent in U.S. communities of color - structural racism pathways are: income, homelessness, unemployment, residental segregation, insurance-healthcare access, incarceration, provider bias, federal laws, and local policies

TAG and COVID-19 Prevention Network Fact Sheets

October 19, 2021
Dorrit Walsh

These three fact sheets were developed by TAG in partnership with the COVID-19 Prevention Network (CoVPN) and the Black AIDS Institute (BAI), and they aim to foster community understanding of COVID-19 vaccine research and development, as well as highlight community perspectives on the topic.